Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00161213
Status:
COMPLETED
Last Update Posted:
2023-08-14
First Post:
2005-09-08
Brief Title:
Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv or Metastatic Pancreatic Cancer
Sponsor:
Organization:
Rutgers The State University of New Jersey